Induction of irreversible growth arrest and terminal dierentiation in human melanoma cells following treatment with recombinant human ®broblast interferon (IFNb) and mezerein (MEZ) results in elevated expression of a speci®c melanoma dierentiation associated gene, mda-7. Experiments were conducted to de®ne the mechanism involved in the regulation of mda-7 expression in dierentiating human melanoma cells. The mda-7 gene is actively transcribed in uninduced HO-1 human melanoma cells and the rate of transcription of mda-7 is not signi®cantly enhanced by treatment with IFN-b, MEZ or IFN-b+MEZ. The high basal activity of the mda-7 promoter in uninduced melanoma cells and the absence of enhancing eect upon treatment with dierentiation inducers is corroborated by transfection studies using the promoter region of mda-7 linked to a luciferase reporter gene containing the SV40 polyadenylation signal sequence. RT ± PCR analysis detects the presence of low levels of mda-7 transcripts in uninduced and concomitant increases in dierentiation inducer treated HO-1 cells. However, steady-state mda-7 mRNA is detected only in IFN-b+MEZ and to a lesser degree in MEZ treated cells. We show that induction of terminal dierentiation of HO-1 cells with IFN-b+MEZ dramatically increases the half-life of mda-7 mRNA while treatment with cycloheximide results in detectable mda-7 mRNA in control and inducer treated cells. These observations con®rm constitutive activity of the mda-7 promoter in HO-1 cells irrespective of dierentiation status suggesting posttranscriptional processes as important determinants of mda-7 expression during terminal dierentiation. The 3' UTR region of mda-7 contains AU-rich elements (ARE) that contribute to rapid mda-7 mRNA turnover during proliferation and reversible dierentiation, a process controlled by a labile protein factor(s). Substitution of the SV40 polyadenylation signal sequence in the luciferase reporter plasmid with the mda-7-ARE-3'-UTR renders the Luciferase message unstable when expressed in proliferating and reversibly dierentiated melanoma cells. In contrast, the luciferase message is stabilized when the mda-7-ARE-3'-UTR construct is expressed in terminally dierentiated HO-1 cells. These results provide compelling evidence that mda-7 expression during terminal dierentiation in human melanoma cells is regulated predominantly at a posttranscriptional level. Oncogene (2000) 19, 1362±1368.
Induction of irreversible growth arrest and terminal dierentiation in human melanoma cells following treatment with recombinant human ®broblast interferon (IFNb) and mezerein (MEZ) results in elevated expression of a speci®c melanoma dierentiation associated gene, mda-7. Experiments were conducted to de®ne the mechanism involved in the regulation of mda-7 expression in dierentiating human melanoma cells. The mda-7 gene is actively transcribed in uninduced HO-1 human melanoma cells and the rate of transcription of mda-7 is not signi®cantly enhanced by treatment with IFN-b, MEZ or IFN-b+MEZ. The high basal activity of the mda-7 promoter in uninduced melanoma cells and the absence of enhancing eect upon treatment with dierentiation inducers is corroborated by transfection studies using the promoter region of mda-7 linked to a luciferase reporter gene containing the SV40 polyadenylation signal sequence. RT ± PCR analysis detects the presence of low levels of mda-7 transcripts in uninduced and concomitant increases in dierentiation inducer treated HO-1 cells. However, steady-state mda-7 mRNA is detected only in IFN-b+MEZ and to a lesser degree in MEZ treated cells. We show that induction of terminal dierentiation of HO-1 cells with IFN-b+MEZ dramatically increases the half-life of mda-7 mRNA while treatment with cycloheximide results in detectable mda-7 mRNA in control and inducer treated cells. These observations con®rm constitutive activity of the mda-7 promoter in HO-1 cells irrespective of dierentiation status suggesting posttranscriptional processes as important determinants of mda-7 expression during terminal dierentiation. The 3' UTR region of mda-7 contains AU-rich elements (ARE) that contribute to rapid mda-7 mRNA turnover during proliferation and reversible dierentiation, a process controlled by a labile protein factor(s). Substitution of the SV40 polyadenylation signal sequence in the luciferase reporter plasmid with the mda-7-ARE-3'-UTR renders the Luciferase message unstable when expressed in proliferating and reversibly dierentiated melanoma cells. In contrast, the luciferase message is stabilized when the mda-7-ARE-3'-UTR construct is expressed in terminally dierentiated HO-1 cells. These results provide compelling evidence that mda-7 expression during terminal dierentiation in human melanoma cells is regulated predominantly at a posttranscriptional level. Oncogene (2000) 19, 1362±1368.
Keywords: human melanoma; posttranscriptional gene regulation; 3'-UTR; AUUUA Conventional cancer therapy often involves surgery followed by repeated rounds of chemotherapy and/or radiation (Patterson and Harris, 1999) . Although this approach can in speci®c instances result in complete cancer remission, in the majority of cases it is associated with severe toxic side eects and often results in only a transient abatement of the diseasestate. An alternate approach for treating cancer employs agents that are potentially less toxic and which modulate the dierentiation of tumor cells, a process termed`dierentiation therapy' (Huberman and Callaham, 1979; Sachs, 1980; Scott and Maercklein, 1985; Waxman et al., 1991; Jiang et al., 1994; Waxman, 1995; Scott, 1997; Tamayo et al., 1999) . In many instances, neoplastic growth results from the failure of cancer cells to undergo normal programs of dierentiation. It is hypothesized that this de®ciency to respond to the appropriate cell growth and dierentiation signals is a consequence of lack of expression or reduced expression of genes necessary for maintaining these processes in cancer cells, rather than mutation and loss of function of these genetic elements. This hypothesis is supported by the observation that speci®c dierentiation inducers can reprogram gene expression in cancer cells to that of more normal cells resulting in a concomitant loss of proliferation ability and induction of terminal dierentiation (Waxman et al., 1991; Jiang et al., 1994; Waxman, 1995; Wada et al., 1997) . Lack of proper gene expression in cancer cells may be a consequence of defects in transcriptional and/or posttranscriptional events that result in the loss of threshold levels of functional gene products required to induce terminal cell dierentiation. In the case of human melanoma cells, a combinatorial treatment protocol comprising IFN-b plus MEZ results in a rapid and irreversible loss of growth potential and terminal dierentiation (Fisher et al., 1985; Jiang and Fisher, 1994; Jiang et al., 1994) . To de®ne the gene expression changes associated with and potentially controlling growth and dierentiation in human melanoma cells a modi®ed subtraction hybridization scheme is being used . This strategy has resulted in the identi®cation and cloning of a series of melanoma dierentiation associated (mda) genes implicated in growth control, dierentiation and apoptosis Jiang et al., 1994 Jiang et al., , 1995a Jiang et al., ,b, 1996 Su et al., 1998; Huang et al., 1999a,b; Madireddi et al., 2000) .
One of the mda genes, mda-7, is a novel gene whose expression correlates with the induction of terminal dierentiation in human melanoma cells (Jiang et al., 1995a) . This gene is expressed at high levels in actively proliferating normal human melanocytes, whereas its expression is reduced during disease progression to metastasis (Jiang et al., 1995a) . The mda-7 cDNA encodes a polypeptide of 23.8-kDa and when ectopically expressed in tumor cells of various origins induces growth suppression and apoptosis (Jiang et al., 1995a (Jiang et al., , 1996 Su et al., 1998; Madireddi et al., 2000) . The cellular function of mda-7 remains to be de®ned, however recent ®ndings suggest a potential involvement of this gene in chromatin remodeling during mitosis and dierentiation (data not shown). On the basis of mda-7's signi®cant functions in mitosis, dierentiation and induction of programmed cell death in diverse cancer cell types, analysis of its gene expression controls is warranted. Foremost in this analysis is the fundamental premise of the`dierentiation therapy' hypothesis, i.e., dierentiation drug induced transcriptional and/or posttranscriptional changes may directly in¯uence the production of stable and functional gene products involved in terminal cell dierentiation.
A general mechanism by which diverse organisms regulate gene expression is by controlling the cytoplasmic concentration of individual gene transcripts (Rajagopalan and Malter, 1997) . Cellular RNA levels are generally altered by changes in transcription, RNA processing and mRNA decay (Ross, 1996; Fontes et al., 1999) . Although the process of mRNA synthesis is well understood, the cellular mechanisms controlling RNA degradation are less clear. Nonetheless, recent studies indicate that gene expression can be regulated through changes in mRNA stability as a consequence of altering physiological conditions (Belasco and Higgins, 1988; Spicher et al., 1998) . A growing inventory of genes, including growth factors (Shaw and Kamen, 1986) , cytokines (Aharon and Schneider, 1993) , and proto-oncogenes (Shyu et al., 1991) , are regulated by posttranscriptional decay of their messages. The magnitude of change in gene expression due to posttranscriptional mechanisms is often relatively small, yet even a 2 ± 3-fold increase or decrease in mRNA or protein abundance can have a signi®cant biological impact (Spicher et al., 1998) . With speci®c oncogenes and their normal cellular homologs, such as v-fos and c-fos, respectively, changes in the 3'-untranslated region (UTR) can profoundly aect phenotypic properties. V-fos is capable of transforming normal rat ®broblast cells, whereas c-fos is impaired in this function. However, deletions in the 3'-UTR region of c-fos convert this proto-oncogene into a transforming oncogene (Miller et al., 1984) . It is postulated that the speci®c deletions of the 3'-UTR result in the stabilization of the c-fos mRNA, thereby inducing an abnormal level of c-FOS protein and oncogenic properties.
Little is currently known about expression control and regulation of the mda-7 gene during proliferation and terminal dierentiation. To understand potential transcription and posttranscriptional regulatory factor(s) determining mda-7 gene expression, we have cloned and begun to characterize the promoter of this gene. The mda-7 gene is transcribed and its promoter is operative in uninduced HO-1 human melanoma cells, whereas stable mRNA is only detected in HO-1 cells treated with IFN-b+MEZ and to a much lower extent in MEZ treated cells. The half-life of mda-7 mRNA increases in terminally dierentiated HO-1 cells and cycloheximide treatment results in discernible mda-7 mRNA in uninduced and inducer treated HO-1 cells. An important aspect of mda-7 gene expression regulation is posttranscriptional control by message destabilization regulated by the presence of AUUUA destabilization consensus sequences found in its 3'-UTR. During terminal dierentiation the mda-7 message is stabilized. The present experiments indicate that a major level of mda-7 gene expression regulation occurs posttranscriptionally by altering mRNA stability thereby insuring a precise regulation of gene expression and its functional consequences during human melanoma terminal dierentiation.
Cloning of the mda-7 promoter and activity of the promoter in uninduced and differentiation inducer treated human melanoma cells Expression of mda-7 corresponds with induction of terminal dierentiation in human melanoma cells (Jiang et al., 1995a) . Northern blotting reveals a signi®cant amount of stable mda-7 message when human melanoma cells (HO-1) are induced to terminally dierentiate after a 24 or 96 h treatment with a combination of IFN-b plus the PKC activator MEZ (Jiang et al., 1995a) . Quantitatively less mda-7 mRNA is also apparent in HO-1 cells treated only with MEZ for 96 h (Jiang et al., 1995a) . However, unlike IFNb+MEZ which induce irreversible growth arrest and terminal dierentiation in HO-1 cells, MEZ induced growth suppression and dierentiation are reversible (Fisher et al., 1985; Jiang et al., , 1994 Jiang et al., , 1995a . Removal of MEZ from HO-1 cells followed by replacement with fresh growth medium (DMEM, 5% FCS) results in a loss of dierentiated properties and a return to control growth rates (Fisher et al., 1985; Jiang et al., , 1994 Jiang et al., , 1995a . In this reversible dierentiation process, removal of MEZ results in abrogation of mda-7 expression. This ®nding suggests that mda-7 gene expression is directly responsive to MEZ treatment and may be activated by a PKCmediated pathway. The signi®cant dierence in the accumulation of mda-7 message following induction of terminal dierentiation versus induction of reversible dierentiation implicates posttranscriptional processes, such as mRNA processing and/or stabilization, in sustaining steady state mda-7 message levels in terminally dierentiated HO-1 cells.
To de®ne the mechanism of mda-7 gene regulation and to establish a possible role for transcriptional activation of the mda-7 gene during melanoma terminal dierentiation, the promoter region of this gene was isolated from human genomic DNA and characterized. A 2.2 Kbp genomic fragment upstream of the human mda-7 cDNA was isolated from a human placental genomic library (Stratagene) using a PCR-based method, cloned into pBluescript and the DNA sequence was determined. The full-length presumptive mda-7 promoter nucleotide sequence was searched using the GCG FINDPATTERN program to determine putative transcription factor (TF) binding sites. The transcription start site was determined by primer extension and mapped to a position 274 bp upstream from the open reading frame of the human mda-7 cDNA (data not shown). The GCG promoter search results reveal a putative TATA homology element located between positions 725 to 731 and the areā anking this region is GC rich as is the case for TATA box domains. Some of the transcription factor binding sites that may be relevant to mda-7 gene expression are, AP1 and AP2 (PKC activated TF) and C/EBP (growth arrest and terminal dierentiation associated TF). Several additional transcription factor binding sites, such as SP1, CREB, CBP, Elk1 and p53, are also predicted by GCG.
The presumptive promoter fragment was assayed for promoter activity using a heterologous gene reporter system (pGL3-Basic, luciferase assay system, Promega). The full-length promoter-luciferase construct (FL-mda-7 promoter) was transiently transfected into HO-1 and MeWo human melanoma cells using Superfect R reagent (Qiagen) and untreated or treated with IFN-b, MEZ or a combination of IFN-b+MEZ, and assayed for luciferase expression 48 h later (Promega Luc + assay kit). The transfection eciency was determined by cotransfection with RSV-b-galactosidase (Tropics b-Gal assay kit) and the relative luciferase activity was computed after correction for variations in transfection eciencies. As shown in Figure 1 , the putative FLmda-7 promoter construct displays high levels of basal activation in uninduced HO-1 and MeWo cells in comparison with the pGL3-Basic control plasmid. When treated with IFN-b for 48 h the activity of the FL-mda-7 promoter decreases relative to uninduced HO-1 and MeWo cells (Figure 1) . In several studies, treatment of HO-1 or MeWo with MEZ or IFNb+MEZ for 48 h results in only small changes in mda-7 promoter activity (data not shown). Similar modest changes in mda-7 promoter activity were observed following dierentiation inducer treatment in another human melanoma cell line 3S5, a derivative of the MeWo cell line (Ishikawa and Kerbel, 1989) , stably expressing luciferase under the control of the FL-mda-7 promoter (data not shown).
In summary, promoter assays indicate that modulation of mda-7 gene expression during dierentiation in human melanoma cells may not be controlled at the level of transcription. Instead, they suggest an alternate mechanism for regulating mda-7 mRNA levels in terminally dierentiated melanoma cells. One possible mechanism is posttranscriptional regulation of mRNA stability. Experiments described below were designed to determine if mRNA stability/instability contributes to the dierential regulation of mda-7 gene expression during human melanoma terminal dierentiation. mda-7 mRNA is unstable in uninduced and single differentiation inducer treated human melanoma cells and is regulated by AU-rich elements present in the 3'-UTR Based on the Northern blotting results it appears that mda-7 mRNA is present during IFN-b+MEZ treatment and to a signi®cantly lesser extent during treatment with only MEZ (Jiang et al., 1995a) . However, the promoter is active in undierentiated melanoma cultures and remains active during dierentiation inducer treatment of human melanoma cells (Figure 1 ). To con®rm that the mda-7 gene is transcriptionally active in uninduced and dierentiation inducer treated HO-1 cells, nuclear run-on experiments were performed. Transcription of the housekeeping gene, GAPDH served as an internal control. The results shown in Figure 2a indicate that, the polymerase densities and presumably, therefore, the rates of transcription are the same for uninduced control and MEZ and IFN-b+MEZ treated HO-1 cells. Only in the case of IFN-b alone does the rate of transcription appear to be reduced relative to the other three conditions. These results suggest that the decreased steady-state level of mda-7 mRNA in MEZ treated cells and the undetectable levels by Northern blotting in uninduced and IFN-b treated cells are most probably the result of posttranscriptional events that regulate message stability. To determine the possible Figure 1 The eect of dierentiation inducer drug treatment on full-length mda-7 promoter activity. Fold induction of the FLmda-7 promoter relative to the pGL3-Basic plasmid with or without dierentiation drug inducer treatment in HO-1 (a) or MeWo (b) human melanoma cells. Luciferase assays were performed as previously described (Gopalkrishnan et al., 1999) . In brief, the promoter-containing plasmids were transiently transfected into the dierent cell types using Superfect R (Qiagen) according to the manufacturer's protocol. The cells were treated with dierentiation inducers (IFN-b, 2000 units/ml; MEZ, 10 ng/ ml; or IFN-b+MEZ, 2000 units/ml+10 ng/ml) for 48 h following transfection and assayed for luciferase activity using the Luc+ Assay Kit (Promega). The SV40-b-Galactosidase plasmid was co-transfected with the luciferase constructs and used to normalize for variations in transfection eciencies between experiments. All experimental points were performed in triplicate and individual experiments were repeated a minimum of two times. A representative experiment is presented and standard deviations are indicated for each sample, which represents the average of triplicate reactions presence of trace amounts of mda-7 mRNA in response to dierentiation inducer treatment (IFN-b) and in the absence of treatment, a more sensitive method of message detection was employed, i.e., RT ± PCR followed by Southern blotting. As shown in Figure  2b , mda-7 mRNA (by RT ± PCR) is present in uninduced, IFN-b and MEZ treated cells, albeit at lower levels, compared to IFN-b+MEZ treated samples.
Having demonstrated the presence of mda-7 mRNA in uninduced and IFN-b, MEZ and IFN-b+MEZ treated samples, experiments were performed to determine the mechanism regulating steady state mRNA levels. Analysis of the complete mda-7 cDNA sequence reveals the presence of AU-rich sequences in its 3'-UTR (Figure 2c ). Many transiently expressed genes, including lymphokine and other cytokine genes and the proto-oncogenes c-myc and c-fos, contain AUrich sequences in their 3'-UTRs (Shaw and Kamen, 1986 ). Several studies demonstrate that the presence of AU-rich elements (ARE) in eukaryotic mRNAs correlate with rapid mRNA turnover and posttranslational control (Shaw and Kamen, 1986; Aharon and Schneider, 1993; Rajagopalan and Malter, 1997) . The ARE consists of multiple AUUUA motifs or sequences resembling it. Comparison of mda-7 ARE with several cytokine and lymphokine mRNAs is shown in Figure  2c . Mda-7 has three AUUUA elements and the area between these elements is also AU-rich.
To examine the posttranscriptional regulation of mda-7 mRNA speci®cally during terminal dierentiation of human melanoma cells, we constructed a Luciferase-mda-7-ARE-3'-UTR plasmid under transcriptional control of either the FL-mda-7 promoter (Figure 3) or the SV40 large T-antigen promoter (data not shown). These plasmids were co-transfected into HO-1 cells and treated with dierentiation inducers. In uninduced cells the luciferase activity is minimal as is the case when HO-1 cells are treated with IFN-b or MEZ alone (Figure 3a) . In contrast, luciferase enzyme activity is increased in terminally dierentiated (IFNb+MEZ treated) HO-1 cells (compare the results shown in Figure 1a with Figure 3a) . Kinetic analyses of luciferase activity using this modi®ed construct over a 3-day period document a signi®cant temporal increase in activity (Figure 3b) . Similar results were obtained with a plasmid construct containing an SV40 large T-antigen promoter instead of the mda-7 promoter plus the mda-7 ARE 3' UTR sequence (data not shown). Based on these observations we conclude that the steady state level of mda-7 mRNA is determined by posttranslational decay of the message, which is apparent in uninduced and in HO-1 cells treated singularly with IFN-b or MEZ. However, in IFN-b+MEZ treated cells that are terminally dierentiated, the mda-7 message does not undergo rapid degradation.
To demonstrate enhanced message stability of mda-7 speci®cally in terminally dierentiated cells, the rate of mRNA decay was determined. HO-1 cells were treated with dierentiation inducers followed by incubation with actinomycin D for 30 and 60 min. Northern blotting results reveal that the mda-7 message has a very short half-life, approximately 1 h in terminally dierentiated HO-1 cells (Figure 4a) . However, its half-life is signi®cantly less in control, IFN-b and MEZ alone treatment conditions (less than 15 min, data not shown). The lability of such messages which decay with a half-life of approximately 30 to 60 min distinguishes them from most mammalian messages, which typically are more stable, with half-life's ranging from hours to days (Krowczynska et al., 1985) . These results suggest that stable expression of mda-7 mRNA during HO-1 terminal dierentiation results from posttranscriptional enhancement of message stability. Figure 1 . GAPDH was used as an internal control. In vitro transcription assays were performed as previously described . (b) Mda-7 message expression detected by Northern blotting and RT ± PCR followed by Southern blotting. Total RNA from control (C) HO-1 cells and cells treated with IFN-b (I), MEZ (M) or IFN-b+MEZ (I+M) were analysed by Northern blotting or RT ± PCR/ Southern using radiolabeled mda-7 cDNA as a probe as previously described (Jiang et al., , 1995a Kang et al., 1998a) . GAPDH was used as an internal loading control. (c) Several cytokine genes and proto-oncogenes that contain the AUUUA consensus sequence in their 3'-UTRs. Abbreviations: Hu=human; mda-7=melanoma dierentiation associated gene-7 (Jiang et al., 1995a) ; a-IFN=alpha interferon (Goeddel et al., 1981) ; GM-CSF=granulocyte-monocyte colony stimulating factor (Wong et al., 1985) ; TNF=tumor necrosis factor (Nedwin et al., 1985) ; cFos=fos proto-oncogene (van Straaten et al., 1983) Several studies on intrinsically unstable mRNAs demonstrate that drugs, which inhibit protein synthesis, increase their stability (Raj and Pitha, 1981; Elder et al., 1984; Linial et al., 1985) . The eect of protein synthesis inhibitors was tested using cycloheximide, a compound that inhibits peptide bond formation. The accumulation of mda-7 is visibly increased with cycloheximide treatment in MEZ treated samples and to a lesser extent in control and IFN-b treated samples (Figure 4b ). In contrast, the cyclin-dependent kinase inhibitor p21/Waf1/Cip1/mda-6, a gene that is upregulated during HO-1 terminal dierentiation Jiang et al., 1994 Jiang et al., , 1995b does not show message accumulation in the presence of cycloheximide. Based on these observations we conclude that inhibition of protein synthesis enhances the stability of mda-7 mRNA, and this eect may be a consequence of inhibition of the de novo synthesis of speci®c labile factor(s) that target the ARE sequences in the mda-7 3'-UTR for rapid mRNA degradation.
Discussion
Treatment of human melanoma cells with IFNb+MEZ results in irreversible growth suppression and terminal dierentiation (Fisher et al., 1985; Jiang et al., , 1994 . These processes correlate with profound changes in cellular physiology, including morphological alterations with the development of dendrite-like processes, enhanced melanin synthesis, modulation of the antigenic phenotype and a loss of tumorigenic potential in athymic nude mice. In addition, gene expression programs are dramatically altered during growth suppression and terminal dierentiation, including the modi®ed expression of genes regulating cell cycle progression, transcriptional control, cytoskeletal architecture and novel genetic elements with unde®ned functions Jiang et al., , 1994 Jiang et al., , 1995a Jiang et al., ,b, 1996 Kang et al., 1998b; Huang et al., 1999a,b) . A potentially relevant gene whose expression corresponds with induction of irreversible growth arrest and terminal dierentiation in human melanoma cells is the novel gene mda-7 (Jiang et al., 1994 (Jiang et al., , 1995a . During melanoma progression, mda-7 levels are elevated in normal melanocytes, nevi and radial growth phase primary melanomas, whereas expression of this Figure 3 Posttranscriptional regulation of Luciferase mRNA as a consequence of mda-7-3' UTR addition at its 3'-end. The Luciferase expression plasmid having SV40 polyadenylation signal sequence was replaced with the 3'-UTR region (approximately 900 bp) of mda-7. A schematic representation of this chimeric construct is shown above the data. (a) Mda-7 3'-UTR mediated destabilization of luciferase mRNA was computed as fold induction of luciferase enzyme activity, which is seen only when stable luciferase mRNA, is synthesized. Compare the result shown in Figure 1a of uninduced and IFN-b and MEZ treated samples. The relative activity is very high as shown in Figure 1 as the 3'-UTR used in that assay came from SV40 while the 3'-UTR used in this study was replaced with the mda-7 3'-UTR. Similar results were obtained when an SV40 large T-antigen promoter was used in place of the mda-7 promoter (data not shown). (b) Kinetic analysis of luciferase activity (as fold-induction) of the mda-7 promoter-luciferase-ARE-3'-UTR construct as a function of time of treatment with IFN-b+MEZ. Luciferase assays were performed as described by Gopalkrishnan et al. (1999) Figure 1 . Twenty-four hours after exposure to the inducing agent(s), actinomycin D (Act.D, 5 mg/ml) was added (+Act.D) for 30 min (30'') or 1 h (1'). Mda-7 expression was detected using a radiolabeled mda-7 cDNA probe as previously described (Jiang et al., 1995a) . rRNA visualized by ethidium bromide was used as a loading control. (b) Eect of cycloheximide treatment on mda-7 mRNA stability relative to p21/mda-6. Untreated control (C) HO-1 cells or cells treated for 24 h with IFN-b (I), MEZ (M) or IFN-b+MEZ at the same concentrations as in Figure 1 . After 24 h induction, cells were treated with or without cycloheximide (10 mg/ml) for 3 h and total RNA was isolated and analysed by Northern blotting. mda-7 expression was detected using a radiolabeled mda-7 cDNA probe (Jiang et al., 1995a) . The blot was allowed to decay for 3 months, and then reprobed using a radiolabeled probe against a p21/mda-6 cDNA (Jiang et al., 1995b) . rRNA visualized by ethidium bromide was used as loading control gene is reduced or undetected in late vertical growth phase primary melanomas and metastatic melanomas (Jiang et al., 1995a) . The ability of IFN-b+MEZ to induce a reversion in gene expression to a more normal melanocytic state and induce terminal dierentiation in human melanoma cells that coincides with renewed expression of mda-7 provides support for the`dierentiation therapy' hypothesis. In this context, understanding the role of mda-7 in the dierentiation process should provide relevant insights into growth control and terminal dierentiation in human melanoma cells.
Although mda-7 is not detected by Northern blotting in proliferating HO-1 cells, treatment with IFNb+MEZ for 24 h results in induction of this gene (Jiang et al., 1994 (Jiang et al., , 1995a . To de®ne the mechanism underlying mda-7 induction and maintenance during dierentiation in human melanoma cells we have isolated the promoter region of this gene and determined the relationship between transcriptional and posttranscriptional processes in controlling mda-7 gene expression in human melanoma cells. These studies emphasize that a major component of mda-7 gene expression during terminal dierentiation involves alterations in the stability of mda-7 mRNA. In uninduced and reversible dierentiation induced (IFN-b or MEZ treatment) HO-1 cells the mda-7 message is produced (as indicated by RT ± PCR) but it is unstable, whereas in terminally dierentiated (IFNb+MEZ treated) HO-1 cells mda-7 mRNA is stabilized resulting in production of MDA-7 protein.
In the present study we document that mda-7 gene expression is regulated posttranscriptionally, i.e., by altering message stability. Domain swapping mRNA stability analyses using the luciferase gene reporter system and the mda-7 mRNA destabilization domain (3'-UTR-AUUUA) relative to the SV40 polyadenylation signal sequence were performed. These studies document that the AU-rich sequences in the 3'-UTR of mda-7 function at the posttranscriptional level and speci®cally decrease the accumulation of the mda-7 transcript. This eect is caused by a marked reduction in reporter gene (luciferase) activity, and hence mRNA stability. Posttranscriptional regulation is particularly important for short-lived proteins such as cytokines and regulators of cell proliferation. The sequences responsible for the posttranscriptional regulation of mRNAs are often found within the 3'-UTR of the transcript. It has been documented that deletion and point mutation alterations of the ARE consensus motif results in altered mRNA stability (Shaw and Kamen, 1986) . The mRNAs of transiently expressed genes frequently contain an AU-rich sequence in the 3' untranslated region. The synthetic introduction of G's and C's in the AU-rich sequence of the human GM-CSF 3' UTR results in a signi®cant alteration in the level of mRNA accumulation (Shaw and Kamen, 1986) . The mRNA level for the wild-type AU-rich sequence is drastically reduced (to less than 3%) in comparison to the mutant GC-rich sequence (Shaw and Kamen, 1986) . Measurement of the half-lives of the AU-rich versus the GC-rich sequence revealed that the AU-rich mRNA decays with a half-life of less than 30 min to a nearly undetectable level by 1 h, whereas the GC-rich sequence remained stable for over 2 h (Shaw and Kamen, 1986) . Uridine pulse-chase experiments indicate that the AU-mRNA decays at a more rapid rate (t 1/2 less than or equal to 30 min) than the stable GC-mRNA (Shaw and Kamen, 1986 ). These observations suggest that the presence of the AU sequence in the 3'UTR speci®cally confer instability to mRNAs. The magnitude of this eect is sucient to explain the lack of accumulation of the mda-7 gene in proliferating cells and those treated singularly with IFN-b and MEZ.
A recent report (Spicher et al., 1998) documents the existence of at least ten dierent highly conserved regions (HCRs) within the 3'-UTRs that are capable of altering gene expression at the posttranscriptional level. The presence of multiple repeats of one such mRNA destabilization motif in the 3'-UTR of the mda-7 message lends itself to further regulation of its gene expression. It is unclear at this time if the increase in mda-7 mRNA is the result of selective stabilization during melanoma terminal dierentiation or dierential destabilization during proliferation. The ®eld of mRNA stability is expanding at an accelerated rate with numerous reports of proteins implicated in the ARE mediated mRNA decay process. One such protein is the HuR protein that selectively binds ARE sequences in vitro and causes their selective destabilization (Myer et al., 1997) . One theme that is common among all of these reports is that addition of protein synthesis inhibitors alleviates message instability, and mda-7 mRNA is no exception to this rule. Cycloheximide addition reverses the instability of the mda-7 message in control and MEZ alone treated cells. This ®nding demonstrates the requirement for protein translation for the destabilization event and implicates a labile factor(s) in this process.
In summary, mda-7 gene expression in human melanoma cells is regulated posttranscriptionally by regulation of its message stability by unknown mRNA degradation factor(s) during terminal dierentiation in melanoma cells. In this respect, the alterations observed in mda-7 gene expression with melanoma disease progression provide support for the aberrant dierentiation/gene expression model of melanoma development (Jiang et al., 1994) and provide a scienti®c basis for the successful application of`dierentiation therapy' (IFN-b+MEZ) in this cancer model system. The evolution and progression of cancer cells from normal cells may be a direct consequence of changes in transcriptional and/or posttranscriptional events resulting in a loss or decrease in the amount of gene products that control normal cell growth and dierentiation. In this context, mda-7 may represent an important gene product that functions as a negative regulator of human melanoma progression.
